uniqu
featur
vanadium
v
receiv
great
deal
attent
chemist
biologist
biochemist
toxicologist
pharmacologist
biolog
activ
element
prompt
investig
mani
organ
v
complex
inorgan
compound
term
potenti
use
treatment
certain
diseas
human
studi
carri
far
v
shown
bioactiv
complexescompound
metal
therapeut
activ
low
concentr
take
account
clear
interest
antivir
antibacteri
antiparasit
antifung
anticanc
antidiabet
antihypercholesterolem
cardioprotect
neuroprotect
activ
v
possibl
use
element
treatment
obes
present
review
focus
mechan
underli
pharmacolog
potenti
metal
obstacl
use
metallopharmaceut
futur
key
inform
mechan
toxic
essenti
physiolog
role
metabol
v
collect
well
along
select
aspect
illustr
timelin
review
paper
also
summar
avail
literatur
data
use
v
tissu
engin
industri
sector
brief
descript
risk
human
health
addit
report
draw
attent
direct
research
v
interact
metal
element
especi
antioxid
potenti
comprehens
research
interact
v
antioxid
element
summar
graphic
separ
chapter
present
report
particularli
import
view
j
u
r
n
l
p
r
e
p
r
f
illustr
figur
vanadium
v
commonli
use
mani
industri
especi
glass
paint
ceram
photograph
chemic
electrochem
refin
industri
also
use
metallurg
industri
product
steel
nonferr
alloy
vanadiumcontain
steel
high
hard
strength
elast
abras
resist
wide
use
spring
steel
tool
steel
highspe
steel
current
steel
addit
v
vcontain
nonferr
alloy
use
build
jet
engin
machin
part
includ
construct
equip
well
aircraft
automobil
compon
noniron
alloy
contain
v
also
use
space
technolog
nuclear
power
industri
moreov
steel
v
well
suit
product
armor
fight
vehicl
use
second
world
war
detail
vcontain
steel
alloy
still
use
produc
variou
structur
compon
aircraft
weapon
rocket
engin
etc
summar
follow
tabl
tabl
shown
figur
vanadium
also
potenti
candid
therapeut
applic
antivir
antibacteri
antiparasit
antifung
anticanc
antidiabet
antihypercholesterolem
activ
cardioprotect
neuroprotect
antiobes
effect
arous
interest
mani
research
center
worldwid
mani
year
report
human
be
pharmacolog
amount
v
ie
time
higher
normal
intak
affect
cholesterol
triglycerid
metabol
influenc
erythrocyt
shape
stimul
hepat
glucos
oxid
glycogen
synthesi
addit
v
certain
condit
found
act
antioxid
fig
evidenc
anim
studi
detail
mechan
pharmacolog
activ
v
graphic
illustr
summar
anoth
part
present
report
research
certain
aspect
biolog
activ
v
present
fig
demonstr
essenti
role
element
metabol
carbohydr
effect
glycolysi
glycogenolysi
glycogenogenesi
gluconeogenesi
pathway
lipid
stimul
lipogenesi
inhibit
lipolysi
phospholipid
cholesterol
influenc
v
bone
miner
thyroid
erythrocyt
metabol
accumul
transport
calcium
cell
synthesi
secondari
transmitt
mediat
transduct
intracellular
signal
known
well
furthermor
v
also
regul
activ
j
u
r
n
l
p
r
e
p
r
f
key
enzym
involv
phosphoryl
dephosphoryl
protein
kinas
phosphatas
take
part
carbohydr
lipid
metabol
also
cell
prolifer
differenti
physiolog
dualiti
vanadium
essenti
trace
amount
toxic
excess
fig
deficit
excess
concentr
lead
rang
patholog
caus
irrevers
damag
variou
tissu
organ
low
concentr
v
found
exert
benefici
effect
growth
physiolog
function
microorgan
plant
fungi
essenti
element
demonstr
bacteria
genu
azotobact
cyanobacteria
genera
nostoc
anabaena
certain
alga
genera
scenedesmu
chlorella
fucu
bumilleriopsi
brown
alga
ascophyllum
nodosum
fungi
genera
aspergillu
culvularia
amanita
lichen
fig
posit
effect
v
nitrogen
n
fixat
azotobact
suggest
bortel
fig
v
turn
essenti
activ
certain
enzym
bromoperoxidas
brop
nitrogenas
chloroperoxidas
isol
alga
nitrogenfix
bacteria
fungu
culvularia
inaequali
respect
fig
furthermor
vanadium
also
recogn
essenti
proper
growth
develop
certain
anim
first
suggest
essenti
v
anim
appear
ie
nearli
year
first
discoveri
metal
fig
year
later
schwarz
miln
hopkin
mohr
strasia
report
v
necessari
rat
chick
fig
turn
ank
coauthor
also
report
v
essenti
goat
fig
meantim
first
review
physiolog
biochem
effect
v
publish
fig
date
symptom
v
defici
describ
inter
alia
bird
chicken
rat
guinea
pig
goat
substant
evid
v
essenti
found
rat
goat
basi
nielsen
uthu
propos
consid
vanadium
essenti
trace
element
proper
growth
develop
higher
anim
contrast
essenti
metal
human
unproven
fig
although
author
suggest
essenti
trace
element
man
mostli
vanadium
broad
pharmacolog
activ
point
biolog
import
metal
american
dietet
associ
amdassoc
consid
v
essenti
human
nutrit
fig
nevertheless
symptom
v
defici
human
describ
yet
final
proof
essenti
v
human
requir
confirm
specif
function
element
case
alga
fungi
howev
definit
known
high
content
v
environ
diet
harm
anim
human
gener
accept
toxic
v
depend
mani
differ
factor
includ
composit
diet
type
v
compound
inorganicorgan
natur
ligand
attach
v
complex
valenc
dose
rout
entri
metal
organ
durat
actionexposur
individu
speci
sensit
fig
histori
research
advers
effect
action
metal
date
back
priestli
describ
toxic
v
certain
anim
fig
regard
anim
rabbit
guinea
pig
found
sensit
element
mice
rat
fig
turn
classic
paper
toxic
pharmacolog
action
vanadium
written
analys
content
v
variou
organ
initi
year
later
fig
known
condit
v
act
strong
prooxid
interact
synergist
oxid
enhanc
oxid
stress
turn
result
mani
neg
consequ
includ
disintegr
cell
membran
denatur
protein
degrad
dna
fig
may
also
weaken
antioxid
barrier
intensifi
lipid
peroxid
lpo
ie
free
radic
process
underli
one
mechan
cell
damag
fig
addit
v
reduc
thiol
statu
releas
transit
metal
interact
element
accumul
certain
intern
organ
includ
liver
kidney
evok
hepatoand
nephrotox
effect
respect
fig
higher
concentr
v
also
act
proapoptot
factor
j
u
r
n
l
p
r
e
p
r
f
induct
oxid
stress
lead
program
cell
death
apoptosi
damag
mitochondri
membran
cytochrom
c
cyt
c
outflow
activ
caspas
poli
adpribos
polymeras
parp
fig
play
role
cell
death
promot
factor
disord
electron
transport
chain
oxid
phosphoryl
result
decreas
level
atp
advers
effect
v
action
fig
mechan
toxic
v
requir
experiment
work
fulli
elucid
yet
report
implic
advers
effect
v
action
exampl
mechan
v
produc
reprotox
effect
believ
link
oxid
stress
andor
actin
cytoskeleton
damag
fig
suggest
hepatotox
nephrotox
cardiotox
genotox
neurotox
carcinogen
effect
metal
well
inflammatori
fibrot
chang
lung
associ
prooxid
potenti
v
abil
intensifi
lpo
fig
known
lpo
product
stimul
express
oncogen
turn
lead
transform
normal
cell
cancer
cell
fig
epidemiolog
studi
suggest
exposur
elev
level
v
may
risk
factor
cancer
develop
studi
anim
model
reveal
posit
correl
frequenc
neoplasia
suscept
vinduc
inflamm
involv
pathogenesi
mani
diseas
malign
diseas
result
vinduc
oxid
stress
turn
longlast
oxid
stress
simultan
weaken
antioxid
system
present
everi
live
organ
lead
perman
celltissu
damag
consequ
initi
diseas
process
therefor
gener
reactiv
oxygen
speci
ro
oxid
stress
one
main
factor
affect
morbid
lead
damag
dna
consequ
initi
carcinogenesi
risk
anim
human
health
relat
exposur
v
larg
depend
degre
oxid
state
highlight
v
highest
oxid
state
toxic
vanadium
form
one
compound
metal
vanadium
pentoxid
contain
v
highest
oxid
state
report
easili
reach
alveolar
surfac
subsequ
enter
circul
directli
diffus
entir
organ
induc
divers
injuri
risk
poison
pentaval
v
form
constantli
grow
due
extens
releas
environ
metallurg
industri
chemic
plant
oil
refineri
coal
mazutfir
heat
plant
moreov
rel
high
pollut
environ
also
caus
dust
deriv
combust
liquid
solid
fuel
j
u
r
n
l
p
r
e
p
r
f
well
municip
wast
result
increas
risk
exposur
anyon
live
near
area
consequ
level
metal
soil
increas
turn
higher
concentr
v
soil
lead
intens
uptak
metal
plant
due
lack
select
mechan
protect
plant
excess
absorpt
element
thu
v
enter
anim
human
organ
via
food
chain
addit
lack
proper
industri
wastewat
manag
contain
metal
anoth
risk
factor
anim
human
health
case
occup
exposur
worker
repair
thermal
power
boiler
highpressur
combust
engin
well
respons
product
replac
vbase
catalyt
convert
vulner
toxic
pentaval
form
metal
literatur
occup
exposur
describ
etiolog
factor
asthmat
syndrom
known
boilermak
diseas
import
symptom
exposur
v
via
oral
rout
present
fig
includ
gastrointestin
disord
abdomin
pain
nausea
vomit
diarrhea
loss
appetit
weight
reduct
greenblack
tongu
turn
symptom
exposur
metal
inhal
illustr
figur
includ
rhiniti
chest
pain
pharyng
bronchiti
pneumonia
bradycardia
cough
dyspnoea
bronchial
asthma
headach
dizzi
conjunct
blur
vision
apathi
depress
import
issu
metabol
v
form
metal
present
physiolog
fluidstissu
collect
figur
illustr
v
consumpt
depend
diet
estim
around
typic
daili
dose
consum
human
daili
dose
ingest
us
popul
intak
vanad
mainli
reach
gastrointestin
gi
tract
acid
environ
stomach
anion
vanad
absorb
effect
vo
transform
vanadyl
vo
precipit
insolubl
vanadyl
hydroxid
vo
oh
slightli
alkalin
medium
intestin
excret
fece
turn
resorb
v
remov
organ
kidney
probabl
form
unidentifi
complex
high
proteinbound
lowmolecularweight
speci
vo
complex
level
v
urin
estim
around
intak
amount
report
absorpt
v
gi
tract
mainli
estim
rang
although
amount
greater
indic
absorb
well
fig
addit
sanchez
et
al
found
absorpt
rate
v
level
rat
treat
bi
maltolato
oxovanadium
iv
bmov
mgday
drink
water
five
week
highlight
differ
may
associ
sever
factor
inter
alia
diet
composit
andor
chemic
form
ingest
v
furthermor
enter
bloodstream
v
bound
albumin
alb
play
pivot
role
transport
variou
metal
transferrin
tf
prefer
main
v
transport
blood
plasma
tf
alb
bind
v
oxid
state
report
v
form
vanadyl
vo
tetraval
v
state
bind
tf
bind
site
fe
ion
v
cation
form
dioxovanadium
cation
indic
also
occupi
pocket
fe
studi
conduct
azevedo
et
al
confirm
v
v
bind
apotf
holotf
thu
effici
uptaken
cell
receptormedi
endocytosi
tf
addit
tf
bind
v
iii
form
divanadium
iii
tf
v
iii
uptaken
cell
via
receptormedi
endocytosi
well
also
report
v
speci
enter
cell
via
membran
citrat
transport
lactat
transport
organ
anion
transport
organicat
addit
vo
uptaken
via
passiv
diffus
bound
immunoglobulin
g
igg
lowmolecular
compon
plasma
phosphat
citrat
lactat
oxal
turn
v
ion
enter
cell
anion
channel
ie
phosphat
sulfat
channel
cell
v
reduc
vo
reduc
substanc
ascorb
acid
thiolcontain
cystein
instanc
erythrocyt
rbc
v
princip
reduc
glutathion
gsh
vo
bind
hemoglobin
hb
fig
total
content
v
organ
adult
equival
mean
tissu
concentr
nm
half
amount
locat
bone
major
storag
pool
longterm
v
accumul
vanad
substitut
phosphat
miner
hydroxyapatit
oh
fig
amount
mainli
deposit
liver
kidney
spleen
due
import
organ
detoxif
organ
excret
harm
substanc
muscl
lung
brain
site
v
accumul
fig
regard
v
speciat
metal
liver
present
transferrin
lowmolecular
mass
fraction
tff
lmmf
respect
j
u
r
n
l
p
r
e
p
r
f
well
vanadylferritin
fer
complex
ferv
lmmfv
fraction
also
identifi
spleen
kidney
v
divid
high
molecular
mass
fraction
hmmf
lmmf
addit
exchang
fraction
metal
indic
fig
turn
larg
amount
v
lung
identifi
hemoglobin
tf
fraction
hbf
tff
respect
readili
exchang
fraction
fig
discuss
v
term
medic
applic
mention
metal
appli
tissu
engin
obtain
biomateri
allow
regener
damag
tissuesorgan
restor
lost
function
present
anoth
subsect
paper
v
part
metal
biomateri
mainli
titanium
alloy
bioactiv
coat
includ
polymer
coat
diamondlik
layer
appli
surfac
titanium
alloy
order
increas
bioactiv
implant
improv
osseointegr
two
titanium
alloy
v
eli
use
biomed
materi
mainli
bone
surgeri
due
good
mechan
properti
high
resist
corros
biocompat
tabl
addit
name
permendur
anoth
vanadiumcontain
alloy
v
mainli
use
product
devic
support
work
heart
tabl
presenc
vanadium
biomed
materi
requir
addit
comment
sinc
implant
made
titanium
alloy
contain
v
expos
bodi
fluid
v
may
releas
surround
tissu
exert
advers
effect
fact
implant
surfac
signific
impact
reaction
occur
implanttissu
interfac
also
taken
account
therefor
surfac
layer
implant
often
modifi
order
induc
specif
reaction
tissu
implant
case
implant
eg
orthoped
dental
implant
surfac
appropri
bioactiv
rough
creat
achiev
rapid
osseointegr
durabl
connect
biomateri
tissu
report
layer
vari
composit
often
appli
surfac
metal
alloy
order
improv
biolog
activ
implant
provid
addit
barrier
releas
metal
metal
biomateri
exampl
titanium
oxid
base
coat
contain
nanohydroxyapatit
nha
silver
particl
ag
appli
alloy
tabl
nha
ag
layer
use
bioactiv
coat
antimicrobi
properti
increas
biolog
activ
osseointegr
biochem
stabil
implant
medic
devic
tabl
moreov
polymer
vbase
coat
made
poli
lactidecoglycolid
copolym
plga
antimicrobi
activ
tabl
diamondlik
layer
includ
v
vdlc
also
form
use
implant
materi
tabl
research
pharmacolog
potenti
v
vitro
vivo
experiment
model
shown
compoundscomplex
element
effect
mechan
antibacteri
activ
v
fulli
elucid
yet
includ
inhibit
activ
na
k
atpas
fig
b
gener
ro
fig
c
impact
transport
substrat
eg
thymidin
uridin
leucin
glucos
cell
bacteri
cell
membran
fig
along
induct
potassium
k
outflow
cell
interact
topoisomeras
type
ii
gyras
fig
necessari
proper
function
genom
bacteri
growth
atpbind
site
use
target
antibacteri
drug
e
interact
dna
interc
manner
result
modif
dna
structur
unwind
stiffen
elong
doubl
helix
format
interc
complex
f
interact
compon
cytoskeleton
result
morpholog
alter
bacteri
cell
therebi
prevent
proper
divis
g
nonspecif
mechan
action
fig
emphasi
better
bioavail
v
complex
due
presenc
specif
ligand
allow
complex
penetr
hydrophob
lipidrich
bacteria
wall
acc
data
area
obtain
vitro
studi
influenc
v
human
immunodefici
viru
complex
element
shown
inhibit
activ
viral
revers
transcriptas
rt
respons
synthesi
dna
viral
rna
matrix
revers
transcript
process
facilit
integr
viral
dna
genom
host
cell
thu
inhibit
rt
activ
vanadium
block
viral
replic
furthermor
bind
v
complex
molecul
present
surfac
thelper
cell
chemokin
coreceptor
suggest
well
fig
lead
blockag
passag
viru
host
cell
therebi
prevent
multipl
protect
develop
infect
among
mechan
antifung
activ
v
complex
likewis
mechan
antibacteri
antivir
activ
metal
fulli
recogn
yet
interact
dna
intercal
propos
addit
inhibit
biosynthesi
import
compon
fungal
cell
membran
ie
ergosterol
fig
affect
express
gene
involv
synthesi
compound
suggest
j
u
r
n
l
p
r
e
p
r
f
mechan
antiparasit
activ
vanadium
trypanosomiasi
amoebiasi
leishmaniasi
mainli
suggest
vitro
studi
includ
intercal
v
complex
dna
fig
antitryposom
antiamoebiasi
activ
b
inhibit
activ
phosphatas
fig
due
structur
similar
vanad
phosphat
enzym
involv
gluconeogenesi
metabol
pathway
necessari
growth
leishmania
spp
c
inhibit
activ
acid
phosphatas
sacp
fig
virul
factor
commonli
secret
leishmania
growth
activ
respons
releas
ro
proinflammatori
cytokin
includ
capabl
destroy
intracellular
pathogen
activ
leishmania
among
mechan
antitumor
activ
v
compoundscomplex
still
requir
studi
intensifi
ro
gener
includ
ironinduc
ro
follow
ferritin
disintegr
due
v
action
suggest
fig
ro
product
commonli
known
lead
disturb
cellular
metabol
damag
lysosom
mitochondria
critic
maintain
cellular
homeostasi
result
activ
caspas
apoptosi
inhibit
cell
cycl
hyperactiv
rasrafmekerk
pathway
also
propos
fig
pathway
activ
inhibitor
cyclindepend
kinas
thu
maintain
retinoblastoma
protein
prb
hypophosphoryl
form
capabl
block
cell
cycl
involv
v
suppress
neoplast
transform
apoptot
signal
andor
cell
cycl
arrest
also
suggest
chakraborti
et
al
base
evid
anim
studi
moreov
focu
place
interact
v
compon
spindl
b
intercal
dna
fig
c
potenti
antiprolif
activ
inhibit
activ
ib
topoisomeras
topib
fig
capabl
relax
highli
twist
dna
molecul
e
inhibit
activ
neutral
endopeptidas
nep
inactiv
anticanc
enkephalin
f
modul
phase
andor
ii
xenobiot
metabol
enzym
g
alter
antioxid
statu
fig
reduct
gshgssg
ratio
fig
lead
intensif
oxid
stress
cell
highlight
well
addit
v
compound
report
abl
counteract
tumor
metastasi
much
attent
still
focus
studi
design
v
compound
cancer
treatment
evidenc
recent
publish
articl
howev
v
compoundscomplex
use
studi
mainli
test
differ
cell
line
vivo
condit
anim
model
exampl
result
studi
conduct
ni
et
al
show
certain
multident
oxovanadium
iv
complex
promis
anticanc
activ
human
hepatocellular
carcinoma
cell
one
compound
exhibit
much
potent
antitumor
properti
turn
less
toxic
normal
human
cell
cisplatin
complex
suppress
tumor
cell
prolifer
caus
cell
cycl
arrest
directli
induc
apoptosi
dosedepend
manner
emphas
author
structur
element
ie
metal
compon
variat
coordin
mode
labil
water
molecul
chelat
ligand
probabl
exert
essenti
cooper
effect
antitumor
activ
anoth
vitro
studi
demonstr
v
oxidovanadium
iv
complex
vol
bipi
abl
induc
earli
apoptosi
effici
cell
line
normal
cell
moreov
author
reveal
rate
necrosisl
apoptosi
also
induc
cell
potent
cell
base
result
suggest
vol
bipi
complex
consid
new
strategi
treatment
hepatocellular
carcinoma
addit
hypothes
basi
studi
conduct
research
vol
bipi
complex
may
modifi
coapplic
antioxid
safer
administr
thereof
alon
turn
studi
report
kowalski
et
al
reveal
oxidovanadium
iv
coordin
complex
contain
ligand
good
candid
preclin
develop
novel
anticanc
drug
target
pancreat
cancer
suggest
molecular
mechan
cytotox
complex
depend
gener
ro
cell
cycl
arrest
phase
simultan
activ
pathway
earlier
studi
conduct
author
show
select
cytotox
effect
v
complex
contain
phenanthrolin
quinolin
organ
ligand
human
pancreat
ductal
adenocarcinoma
cell
line
result
work
reveal
v
complex
caus
cell
cycl
arrest
phase
induc
signific
increas
ro
gener
timeand
concentr
depend
manner
addit
higher
concentr
v
complex
induc
mix
type
cell
death
cell
includ
apoptot
necroptot
process
author
emphas
type
cell
death
induc
v
complex
mainli
determin
ligand
recommend
studi
support
therapeut
potenti
v
pancreat
cancer
treatment
turn
data
anoth
research
group
examin
effect
substitu
hydrazon
ligand
famili
v
hydrazon
complex
structur
dna
bind
anticanc
activ
reveal
v
complex
exhibit
promis
anticanc
activ
siha
cervic
cancer
cell
experi
demonstr
complex
act
apoptot
mode
nontox
normal
cell
line
recent
anticanc
properti
famili
vanadium
v
complex
diaminotri
phenolato
chelat
ligand
explor
reytman
et
al
demonstr
promis
vitro
efficaci
one
mechan
suggest
insulinlik
effect
v
link
inhibitori
action
element
activ
protein
tyrosin
phosphatas
ptp
fig
effect
result
antagon
relat
structur
similar
vanad
anion
phosphat
anion
inhibit
protein
tyrosin
phosphatas
respons
inactiv
insulin
receptor
insir
play
key
role
glucos
metabol
vanadium
contribut
activ
receptor
presum
prevent
dephosphoryl
tyrosin
phosphoryl
residu
beta
subunit
insir
turn
activ
pathway
kinas
akt
protein
kinas
respons
metabol
carbohydr
lipid
thu
lead
potenti
insulininduc
signal
transduct
consequ
transport
glucos
cell
increas
fig
inhibitori
effect
ro
gener
v
compound
activ
also
propos
fig
addit
vanadium
caus
increas
number
glucosetyp
transport
cell
membran
fig
allow
glucos
molecul
transport
adipocyt
muscl
cell
b
affect
insulinlik
growth
factor
receptor
igfir
inactiv
associ
ptp
c
activ
receptor
nonreceptor
protein
tyrosin
kinas
ptk
stimul
glycogenogenesi
e
inhibit
glycogenolysi
gluconeogenesi
fig
also
highlight
interact
membran
may
import
stabil
v
complex
structur
chang
membran
protein
may
contribut
insulinmimet
mechan
toxic
illustr
figur
first
report
describ
certain
effect
v
action
patient
diabet
mellitu
dm
appear
year
later
tolman
cowork
demonstr
v
directli
influenc
glucos
glu
metabol
suggest
may
play
role
regul
glu
vitro
period
author
report
v
form
vanad
vanadyl
stimul
glu
oxid
rat
adipocyt
turn
j
u
r
n
l
p
r
e
p
r
f
heylig
et
al
describ
antidiabet
properti
v
vivo
first
time
sinc
number
experi
anim
model
v
compound
ie
vanadyl
sulfat
vs
sodium
metavanad
smv
sodium
orthovanad
use
potenti
antidiabet
drug
constantli
grow
exampl
meyerovitch
coinvestig
report
v
abl
normal
blood
glu
level
vivo
model
fig
besid
author
describ
use
v
diabet
mellitu
dm
fig
one
organ
v
compound
ie
bi
ethylmaltolato
oxovanadium
iv
beov
first
synthes
late
use
first
phase
clinic
trial
nondiabet
volunt
fig
year
later
v
compound
use
phase
iia
trial
seven
type
diabet
subject
fig
howev
diabet
program
ceas
fig
akesi
pharmaceut
inc
januari
announc
discontinu
sole
clinic
develop
program
phase
iia
drug
candid
treatment
diabet
mellitu
report
renal
chang
result
dose
use
preclin
safeti
program
caus
decis
fig
vanadium
wellknown
nephrotox
vivo
data
effect
metal
anim
kidney
avail
literatur
exampl
studi
conduct
de
la
tore
et
al
show
certain
marker
nephrotox
serum
creatinin
urea
level
well
urinari
creatinin
concentr
increas
decreas
respect
v
administr
compar
vuntreat
anim
creatinin
clearanc
also
found
lower
vsuppli
rat
moreov
vinduc
morpholog
chang
kidney
signific
influenc
age
renal
effect
metal
observ
well
find
gave
rise
follow
statement
obtain
result
concern
futur
vanadium
compound
administ
treatment
diabet
patient
addit
anoth
studi
rat
demonstr
vinduc
kidney
fibrosi
glomerular
tuft
preglomeruli
pretubul
interstitium
cortex
medulla
turn
earlier
studi
conduct
boscolo
et
al
also
show
alter
urinari
excret
certain
electrolyt
rat
chronic
treat
v
vanadium
compoundscomplex
gener
known
exhibit
insmimet
properti
involv
regul
glu
metabol
illustr
timelin
fig
vanadyl
sulfat
vs
one
inorgan
v
form
often
use
studi
diabet
patient
overal
histori
studi
date
back
cohen
cowork
conduct
first
trial
effect
vs
patient
noninsulindepend
diabet
mellitu
niddm
halberstam
et
al
boden
et
al
also
use
vs
niddm
patient
fig
turn
sodium
metavanad
smv
administ
patient
niddm
insulindepend
diabet
mellitu
iddm
goldfin
et
al
research
use
vs
studi
niddm
patient
fig
j
u
r
n
l
p
r
e
p
r
f
subsequ
year
ie
vs
appli
studi
niddm
obes
iddm
patient
respect
fig
estim
dose
v
capabl
normal
glu
level
blood
rodent
mg
vkgday
level
v
blood
within
rang
effect
human
achiev
dose
mg
vkgday
level
v
blood
within
rang
fig
sum
highest
scientif
interest
devot
studi
potenti
use
vanadium
treatment
diabet
relat
antidiabet
properti
posit
result
administr
v
compound
demonstr
diabet
anim
human
patient
regard
variou
anim
model
diabet
mani
report
research
area
publish
ongo
studi
focus
issu
evidenc
work
adam
et
al
et
al
briefli
adam
research
group
focus
synthesi
new
antidiabet
complex
contain
vanadium
iv
vitamin
author
show
reduc
blood
glucos
level
lower
creatinin
concentr
decreas
activ
glutamatepyruv
transaminas
gpt
serum
diabet
mice
treat
v
iv
vitamin
complex
compar
untreat
diabet
mice
group
turn
data
mous
studi
conduct
et
al
influenc
eight
new
v
compound
organ
mass
test
reveal
v
complex
remark
differ
effect
organ
weight
despit
similar
composit
coligand
stress
author
may
point
separ
metabol
pathway
compound
bodi
role
trident
l
schiff
base
ligand
recent
report
publish
szklarzewicz
et
al
show
studi
compar
v
complex
divers
structur
correl
properti
investig
synthes
three
new
complex
metal
three
differ
oxid
level
iii
iv
v
schiff
base
ligand
show
differ
coordin
metal
ligand
order
compar
physicochem
spectroscop
properti
potenti
antidiabet
drug
far
applic
v
diabet
patient
concern
may
consider
problem
may
pose
risk
toxic
element
highli
toxic
abl
accumul
interact
metal
summari
seriou
side
effect
includ
tissu
v
accumul
experiment
anim
rat
diabet
treat
metal
oral
review
work
j
u
r
n
l
p
r
e
p
r
f
domingo
et
al
report
domingo
provid
summari
side
effect
deriv
oral
administr
v
compound
observ
diabet
patient
known
diseas
diabet
mellitu
cancer
chronic
diseas
requir
chronic
treatment
therefor
emphas
author
longtermchron
administr
v
may
unavoid
lead
longterm
side
effect
result
signific
tissu
v
accumul
thu
toxic
v
could
deriv
chronic
treatment
element
particular
concern
henc
research
question
legitimaci
possibl
applic
v
oral
diabet
therapi
fig
moreov
stress
investig
also
kept
mind
diabet
mellitu
sometim
character
metabol
diseas
patient
live
mani
year
therefor
low
toxic
potenti
drug
particular
concern
result
previou
studi
organ
inorgan
v
compound
shown
element
act
cardioprotect
agent
may
protect
heart
ischemiareperfus
injuri
prevent
hypertens
hypertrophi
myocardium
improv
heart
perform
inhibit
ptp
activ
activ
kinas
akt
protein
kinas
signal
pathway
propos
mechan
respons
vinduc
cardioprotect
fig
akt
known
protein
kinas
b
pkb
respons
phosphoryl
mani
differ
protein
involv
basic
cellular
process
prolifer
growth
migrat
metabol
play
import
role
regul
myocardi
hypertrophi
angiogenesi
acc
activ
pathway
result
phosphoryl
endotheli
nitric
oxid
synthas
eno
respons
catalyz
nitric
oxid
product
fig
turn
initi
mediat
cardioprotect
antihypertroph
activ
play
import
role
regul
vasorelax
diffus
endothelium
vascular
smooth
muscl
activ
cyclic
guanosin
monophosph
cgmp
inhibit
influx
ca
ion
cell
andor
activ
calcium
pump
ca
atpas
activ
potassium
channel
lead
vasodil
furthermor
stimul
glucos
transport
influenc
v
glucos
transport
fig
result
normal
level
myocardi
cell
anoth
mechan
v
cardioprotect
action
propos
studi
conduct
rat
pharmacolog
induc
diabet
addit
vanadium
vanad
show
prohypertens
properti
induc
vascular
smooth
muscl
contract
act
vasoconstrict
agent
increas
intracellular
calcium
ca
concentr
fig
vivo
studi
carri
smooth
muscl
isol
guinea
pig
airway
shown
inhibit
activ
sodiumj
u
r
n
l
p
r
e
p
r
f
potassium
pump
na
k
atpas
element
seem
link
mechan
respons
smooth
muscl
contractil
vasoconstrict
effect
also
demonstr
vanadyl
differ
mechan
action
suggest
compar
propos
vanad
addit
vanadium
vanadyl
may
also
antihypertens
effect
demonstr
studi
conduct
spontan
hypertens
rat
shr
hypertens
induc
fructoserich
diet
fhr
rat
receiv
vanadyl
sulfat
bi
maltolato
oxavanadium
iv
bmov
term
mechan
underli
neuroprotect
effect
v
specul
element
activ
signal
pathway
surviv
signal
inhibit
ptp
therebi
inactiv
forkhead
box
class
foxo
famili
member
fkhr
afx
final
result
suppress
express
apoptosisinduc
factor
bim
fa
ligand
fasl
also
assum
activ
extracellular
signalregul
kinas
erk
fig
vivo
studi
rodent
model
rat
shown
v
administ
form
bmov
lead
increas
intak
v
decreas
water
food
intak
bodi
weight
serum
leptin
lep
concentr
lep
fig
influenc
metal
signal
pathway
lep
pathway
suggest
mechan
underli
chang
fig
believ
increas
activ
block
janu
tyrosin
kinas
ie
substrat
result
blockag
leptin
signal
cascad
phosphatidylinositol
involv
signal
pathway
insulin
in
leptin
lep
fig
therefor
signal
in
lep
block
fig
turn
inhibit
activ
vanadium
lead
activ
leptin
signal
pathway
fig
thu
inhibit
synthesi
neuropeptid
npi
releas
hypothalamu
consequ
appetit
bodi
fat
mass
bodi
weight
reduc
fig
also
increas
leptin
lep
insulin
inss
sensit
decreas
insulin
insr
leptin
lepr
resist
j
u
r
n
l
p
r
e
p
r
f
fig
insr
caus
disturb
synthesi
lipoprotein
chang
blood
plasma
along
lepr
leprrel
hyperleptinemia
hyperlep
report
signific
risk
factor
hypertens
type
ii
diabet
dyslipidemia
atherosclerosi
cardiovascular
diseas
fig
thu
affect
activ
v
induc
signal
pathway
improv
sensit
lep
in
make
element
suggest
use
treat
obes
increas
inss
found
diabet
rat
receiv
vanadyl
sulfat
day
type
ii
diabet
patient
administr
sodium
metavanad
week
noteworthi
also
fact
direct
influenc
organ
membran
lipid
cholesterolsphingolipidrich
microdomain
protein
involv
signal
transduct
concentr
eg
in
receptor
v
enhanc
effect
caus
in
consequ
result
insr
reduct
decreas
insr
demonstr
obes
rat
fafa
zucker
rat
receiv
v
form
organ
deriv
bmov
week
hypertens
rat
chronic
treat
v
compound
administ
drink
water
mechan
antihypercholesterolem
action
v
relat
effect
element
cholesterol
biosynthesi
pathway
shown
figur
vitro
studi
demonstr
v
inhibit
synthesi
steroid
block
util
mevalon
form
reaction
catalyz
hmgcoa
reductas
transform
ipp
phosphorylationdecarboxyl
reaction
fig
increas
catabol
cholesterol
v
anoth
possibl
mechan
action
element
fig
impact
v
stimul
lipoprotein
lipas
lpl
activ
highlight
well
lpl
enzym
control
mani
metabol
process
eg
particip
metabol
lipid
lipoprotein
thu
disord
proper
function
insr
result
develop
atherosclerosi
obes
type
ii
diabet
unfavor
chang
found
lipid
profil
individu
occup
expos
v
work
product
vcontain
steel
fig
increas
j
u
r
n
l
p
r
e
p
r
f
level
highdens
lipoprotein
cholesterol
hdlc
apolipoprotein
apoai
main
hdl
apolipoprotein
serum
decreas
atherogen
indic
tchdlc
ldlchdlc
apobapoai
fig
decreas
cholesterol
andor
lowdens
lipoprotein
cholesterol
ldlc
also
found
serum
type
ii
diabet
patient
week
administr
type
ii
diabet
mellitu
patient
treatment
sodium
metavanad
fig
reduc
cholesterol
level
demonstr
blood
healthi
rat
receiv
mg
month
month
obes
rat
fafa
zucker
rat
treat
sodium
orthovanad
mgml
drink
water
month
diabet
rat
receiv
mgml
mgml
mgml
mmolkgday
sodium
metavanad
mgml
sodium
orthovanad
mgml
organ
v
complex
mgml
bi
curcumino
oxavanadyl
bcov
mmolkgday
drink
water
differ
period
day
week
month
turn
decreas
level
triglycerid
tg
blood
found
obes
rat
fafa
zucker
rat
receiv
mgml
drink
water
month
b
obes
nondiabet
zucker
fatti
rat
zf
diabet
zucker
fatti
rat
zdf
administr
organ
maltol
vanadium
deriv
ie
bi
maltolato
oxovanadium
iv
bmov
mmolkgday
drink
water
bi
ethylmaltolato
oxovanadium
iv
beov
mmolkgday
probe
respect
week
c
diabet
rat
receiv
bcov
bcov
also
shown
reduc
serum
ldl
level
significantli
anim
given
increas
practic
applic
v
medicin
fact
accumul
metal
certain
intern
organstissu
treatment
chronic
diseas
may
signific
problem
still
advis
carri
studi
v
toxic
mechan
toxic
action
fig
also
necessari
studi
pharmacolog
activ
v
well
mechan
absorpt
excret
thereof
moreov
mechan
transport
v
target
organ
uptak
cell
well
vivo
form
metal
influenc
immun
system
deserv
explor
fig
mechan
immun
respons
upon
v
exposur
also
better
clarifi
addit
comprehens
research
interact
v
element
need
well
fig
j
u
r
n
l
p
r
e
p
r
f
metal
interact
affect
cell
metabol
action
organ
consequ
function
entir
organ
still
import
issu
toxicolog
pharmacolog
medicin
therefor
examin
consequ
charact
mechan
interact
v
rais
hope
use
thereof
treatment
certain
diseas
human
element
especi
antioxid
potenti
vivo
experiment
model
still
current
vital
issu
moreov
consid
wellknown
prooxid
properti
v
fact
increas
gener
ro
oxid
stress
play
crucial
role
vinduc
toxic
suggest
author
hepatotox
nephrotox
cardiotox
genotox
neurotox
carcinogen
effect
metal
well
inflammatori
fibrot
chang
lung
associ
redoxact
natur
abil
intensifi
lpo
see
figur
detail
investig
evalu
consequ
possibl
interact
v
antioxid
element
combin
chronic
treatment
even
desir
aspect
also
import
context
occup
exposur
grow
environment
pollut
v
result
studi
conduct
rodent
model
et
al
show
protect
action
mg
prooxid
activ
v
also
provid
evid
benefici
mginduc
limit
increas
hepat
lpo
administr
v
may
result
independ
action
mg
antagonist
interact
v
effect
observ
healthi
rat
expos
v
smv
concentr
mg
vl
supplement
mg
ms
concentr
mg
mgml
week
howev
studi
need
explain
exact
mechan
account
protect
effect
mg
dose
use
vinduc
oxid
stress
liver
find
report
et
al
demonstr
markedli
reduc
level
lpo
bone
healthi
rat
supplement
mg
ms
smv
exposur
mg
vml
chang
mention
previous
liver
also
influenc
independ
action
mg
antagonist
interact
v
moreov
distinct
trend
toward
antagonist
interact
v
mg
reveal
regard
level
lpo
erythrocyt
healthi
rat
expos
smv
mg
vml
ms
supplement
mg
mgml
ad
concentr
v
mention
select
base
earlier
studi
conduct
research
test
similar
v
concentr
rat
model
well
report
level
metal
blood
urin
occup
expos
peopl
compar
note
smvexpos
rat
base
result
obtain
conclud
issu
relat
interact
v
mg
one
element
antioxid
potenti
import
extend
knowledg
j
u
r
n
l
p
r
e
p
r
f
mechan
effect
v
organ
also
essenti
improv
understand
role
mg
prevent
v
toxic
clarifi
mechan
underli
potenti
protect
action
bioelement
v
poison
even
relev
view
fact
longlast
oxid
stress
simultan
weaken
antioxid
system
lead
perman
celltissu
damag
consequ
initi
diseas
process
addit
examin
combin
vmg
effect
mammalian
organ
may
also
help
futur
safe
use
v
medicin
applic
undisput
fact
recognit
dose
element
show
synergisticantagonist
action
toward
may
play
role
medicin
pharmacolog
howev
although
studi
cite
reveal
supplement
mg
v
exposur
benefici
effect
reflect
reduct
level
lpo
certain
cellstissu
healthi
rat
studi
anim
model
conduct
recogn
whether
antagonist
effect
mg
pharmacolog
amount
v
allow
v
exert
benefici
effect
whether
synergist
action
yield
benefici
effect
lower
amount
v
time
ago
matsuda
et
al
demonstr
first
time
v
mg
administ
combin
smv
mgml
ms
mgml
respect
diabet
rat
drink
water
week
synergist
effect
augment
wholebodi
insulin
sensit
glycogen
synthesi
base
find
author
suggest
potenti
role
combin
therapi
trace
element
type
diabet
mellitu
insulinresist
state
diabet
accompani
chang
level
mg
tissu
weaken
antioxid
barrier
oxid
stress
regard
issu
sanchez
et
al
show
treatment
v
mgdefici
rat
correct
mani
alter
gener
mg
defici
subsequ
et
al
evalu
whether
v
treatment
might
affect
alter
mg
metabol
associ
diabet
author
reveal
exist
interplay
interact
element
diabet
rat
stress
result
might
help
clarifi
role
v
antidiabet
agent
exist
literatur
compris
articl
interact
v
mg
report
abl
protect
harm
effect
ro
summari
data
interact
metal
demonstr
date
relat
paramet
investig
rodent
model
present
figur
liver
cal
synergi
also
determin
rough
paramet
mean
rough
sa
e
root
mean
squar
rough
sq
fig
measur
optic
profilometri
threedimension
scale
morpholog
studi
femur
rat
receiv
v
mg
separ
combin
turn
trend
toward
synergist
interact
metal
observ
level
sodium
erythrocyt
narbc
bone
nab
b
concentr
calcium
cak
kidney
c
tenpoint
height
sz
defin
arithmet
averag
height
sum
five
local
maxima
five
local
minima
fig
interact
effect
v
mg
studi
anim
model
also
reveal
paramet
v
intak
v
absorpt
urinari
fecal
v
excret
serum
mg
insulin
concentr
insulin
resist
index
homair
fig
far
histor
outlin
interact
concern
hill
matron
propos
theori
miner
interact
fig
suggest
metal
similar
chemic
physic
properti
would
interact
biolog
georgievskii
describ
synergist
antagonist
interact
certain
element
wherea
del
defin
term
interact
fig
studi
influenc
combin
administr
v
element
antioxid
potenti
date
back
berg
describ
effect
coadministr
v
mg
growth
mortal
chick
fig
yamaguchi
et
al
report
zn
prevent
toxic
effect
v
fig
late
two
report
describ
effect
se
v
toxic
differ
region
rat
brain
synergist
interact
v
mg
glucos
metabol
diabet
rat
addit
influenc
combin
j
u
r
n
l
p
r
e
p
r
f
administr
v
zn
se
rat
describ
fig
research
interact
v
antioxid
element
gain
popular
sinc
sinc
time
report
appear
effect
coapplic
v
cr
iii
mg
rat
fig
moreov
also
report
effect
v
administ
bmov
bioavail
biochem
paramet
serum
excret
content
v
mg
certain
intern
organstissu
healthi
rat
receiv
vcontain
feed
vari
level
mg
magnesium
oxid
mgo
effect
v
bmov
metabol
distribut
mg
biochem
blood
paramet
diabet
rat
receiv
feed
contain
v
mg
mgo
also
ad
attent
given
studi
treatment
v
associ
compound
antioxid
properti
optim
therapeut
potenti
v
compound
minim
possibl
side
effect
even
relev
view
work
conduct
wang
et
al
show
treatment
nacetylcystein
nac
ie
thiol
antioxid
reduc
accumul
ro
oxid
damag
inhibit
vinduc
ro
gener
human
normal
liver
cell
attenu
antitumor
activ
v
human
hepatoma
cell
emphas
author
result
may
help
therapeut
applic
v
compound
along
antioxid
synergist
agent
order
reduc
potenti
toxic
normal
cell
without
affect
antitumor
activ
cancer
cell
addit
research
suggest
combin
administr
v
antioxid
might
benefici
diabet
therapi
recent
protect
action
pyruv
vinduc
oxid
stress
cytotox
demonstr
chines
hamster
ovari
cell
suggest
antioxid
effect
pyruv
especi
abil
neutral
hydrogen
peroxid
may
involv
observ
mechan
protect
sum
comprehens
investig
anim
model
interact
v
antioxid
element
mg
certain
compound
antioxid
properti
dietaryplantderiv
antioxid
particularli
import
would
allow
us
recogn
potenti
antidot
minim
advers
effect
v
result
strong
prooxid
activ
also
evalu
potenti
efficaci
combin
vmg
treatment
certain
modernag
diseas
due
multidirect
biolog
activ
wide
rang
effect
mammalian
organ
vanadium
arous
interest
mani
research
center
worldwid
mani
year
use
metal
medicin
particular
concern
v
compoundscomplex
found
promis
potenti
therapeut
use
benefici
therapeut
properti
report
diseas
interest
could
effect
suggest
number
j
u
r
n
l
p
r
e
p
r
f
studi
use
v
medicin
constantli
grow
potenti
medic
applic
remain
open
question
given
recent
progress
research
pharmacolog
activ
differ
v
compoundscomplex
assum
new
vbase
drug
avail
therapeut
purpos
futur
recent
much
attent
focus
design
v
compound
use
potenti
applic
anticanc
agent
also
ongo
studi
differ
antidiabet
v
complex
futur
safe
use
treatment
diabet
hand
howev
mani
multidirect
studi
v
narrow
therapeut
index
shown
analys
still
requir
element
use
metallodrug
fight
certain
lifethreaten
modernag
diseas
highlight
abil
v
accumul
strong
toxicolog
potenti
import
obstacl
limit
use
metal
pharmacolog
therefor
would
advis
shift
balanc
toward
benefici
action
v
whose
pharmacolog
potenti
repeatedli
reveal
evidenc
result
mani
studi
conduct
varieti
differ
cell
line
anim
model
howev
seriou
challeng
consider
research
still
devot
design
v
complex
low
toxic
suffici
high
efficaci
besid
issu
mention
present
section
titl
vanadium
import
research
trend
need
identifi
suscept
differ
cellstissu
effect
v
follow
aspect
draw
research
attent
identif
v
speci
import
factor
assess
toxic
element
potenti
health
risk
human
fig
b
examin
welldefin
form
metal
term
avail
select
specif
recognit
key
factor
may
affect
mode
v
action
fig
c
biotransform
v
compound
organ
distribut
blood
bioligand
relev
issu
drug
metabol
mechan
action
role
carrier
ligand
may
limit
facilit
transportabsorpt
v
compound
establish
toxic
profil
ligand
e
elucid
role
v
speci
interact
immun
system
modul
transcript
factor
influenc
immun
signal
f
recognit
therapeut
target
pharmacokinet
pharmacodynam
detail
may
help
design
better
effect
vbase
drug
author
declar
conflict
interest
financi
otherwis
author
declar
known
compet
financi
interest
person
relationship
could
appear
influenc
work
report
paper
histor
outlin
certain
issu
link
miner
interact
studi
effect
combin
administr
vanadium
element
antioxid
properti
anim
mainli
rat
mg
magnesium
zn
zinc
se
selenium
cr
chromium
combat
aircraftpart
aircraft
rocketsoth
compon
part
weapon
aircraft
engin
part
fasten
ti
al
v
blackbird
compon
part
aircraft
missil
applic
ti
cr
al
v
compon
part
aircraft
pipe
hydraul
system
ti
al
v
compon
part
aircraft
jet
engin
rocket
engin
hous
weapon
compon
ti
al
sn
v
compon
part
aircraft
land
gear
part
respons
takeoff
land
ti
al
fe
v
compon
part
aircraft
hull
wire
ti
al
cr
sn
v
ti
al
mo
cr
sn
fe
v
aerospac
industri
ti
al
mo
cr
fe
v
ti
al
mo
cr
fe
v
aerospac
industri
ti
al
mo
cr
zr
v
aerospac
industri
ti
mo
al
cr
v
aerospac
industri
j
u
r
n
l
p
r
e
p
r
f
tabl
vanadiumcontain
biomateri
use
medic
devic
ti
al
v
hip
joint
replac
knee
joint
replac
dental
implant
zygomat
implant
bridgescrown
dental
bridg
orthodont
implant
spine
stabil
trauma
devicesbon
fixat
intramedullari
rod
nail
surgic
screwsbon
plate
encapsul
cardiac
pacemak
eli
ti
al
v
medic
implant
ti
al
v
dental
implant
hip
knee
joint
replac
orthoped
implant
trauma
devic
intramedullari
rod
magnet
alloy
permendur
co
fe
v
devic
support
work
heart
biocompat
coat
appli
metal
alloy
antimicrobi
activ
implant
materi
ti
titanium
al
aluminum
v
vanadium
eli
extra
low
interstiti
max
fe
max
nha
titanium
oxidebas
coat
contain
hydroxyapatit
nanoparticl
silver
particl
surfaceco
vdlc
diamondlik
layer
vanadium
dlc
type
carbon
layer
vanadium
pentoxid
plga
poli
lactidecoglycolid
copolym
